Scientists are a step closer to transplanting a kidney without the need for a lifetime of drugs, a new report has revealed today. Researchers found injecting blood or bone marrow cells into people who have just received a donated kidney can reduce the need for drugs that suppress the immune system. The stem cells in the blood and bone marrow help trick the body into tolerating the transplants, according...
HIV drug resistance target find
BBC News
BBC News
A specific protein in the body may be the key to overcoming the increasing problem of resistance to HIV drugs. Inactivating the ITK protein which is involved in the immune response blocks many steps of HIV replication,...
Eli Lilly to help train doctors on drug-resistant TB
Scientific American
Scientific American
By Laura MacInnis GENEVA (Reuters) - U.S. pharmaceutical company Eli Lilly will donate $1 million to train doctors treating tuberculosis (TB), a disease that infects 9 million people every year and kills nearly 2...
Drug violence claims Mexican police chief
The Wichita Eagle
The Wichita Eagle
BY MANUEL ROIG-FRANZIA Washington Post MEXICO CITY - Gunmen assassinated Mexico's national police chief Thursday, blasting him with nine bullets outside his home in the capital and dealing a...
Extremely drug-resistant microbes alarm scientists
The News Tribune
The News Tribune
WASHINGTON - The threat of death-defying bacteria - stubborn organisms that refuse to be conquered by antibiotic medicines - is growing more alarming. Infectious microbes that used to be able to resist only one drug,...
Cases of drug resistant tuberculosis are on the increase in the UK, experts have warned.
Skynews
Skynews
Immigration linked to TB outbreak Researchers looked at cases of the disease in...
FDA warns doctors of organ transplant drugs' risks to pregnant women
Star Tribune
Star Tribune
WASHINGTON - Health regulators reiterated their warning Friday that organ transplant drugs from Roche and Novartis can cause miscarriages and birth defects when used by pregnant women. The Food and Drug Administration...
Analysts see Vertex as top hepatitis C drug developer
The Boston Globe
The Boston Globe
NEW YORK—Vertex Pharmaceutical Inc.'s hepatitis C drug telaprevir will likely dominate the market and its rival, boceprevir, according to several analysts. The companies presented dueling data on each of their...





